Abstract |
In a recent report, authors describe their findings from the Exhale Airway Stents for Emphysema (EASE) trial. In this study, investigators follow patients with emphysema and severe hyperinflation after a novel bronchoscopic lung-volume reduction procedure utilizing paclitaxel-eluting stents. Despite the merits of this randomized, sham-controlled, multi-institutional study, the authors were unable to demonstrate any sustainable benefit for the treatment group upon follow-up. Nonetheless, important lessons can be learned from this trial, which has set a foundation for future investigations.
|
Authors | Mara B Antonoff, Jonathan D'Cunha |
Journal | Seminars in thoracic and cardiovascular surgery
(Semin Thorac Cardiovasc Surg)
Vol. 23
Issue 4
Pg. 263-5
( 2011)
ISSN: 1532-9488 [Electronic] United States |
PMID | 22443642
(Publication Type: News)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Respiratory System Agents
- Paclitaxel
|
Topics |
- Bronchoscopy
(instrumentation)
- Drug-Eluting Stents
- Humans
- Paclitaxel
(administration & dosage)
- Prosthesis Design
- Pulmonary Emphysema
(physiopathology, surgery)
- Respiratory System Agents
(administration & dosage)
- Treatment Outcome
|